ClinicalTrials.gov
ClinicalTrials.gov Menu

Dose-Dense Temozolomide + Lapatinib for Recurrent Ependymoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00826241
Recruitment Status : Unknown
Verified March 2015 by National Institutes of Health Clinical Center (CC).
Recruitment status was:  Active, not recruiting
First Posted : January 22, 2009
Last Update Posted : October 22, 2015
Sponsor:
Collaborator:
CERN Foundation - Collaborative Ependymoma Research Network
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC)

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : January 2017
  Study Completion Date : No date given